medijel oral gel
ddd limited , uk (0000003551) 94 rickmans worth road , watford, herts. wd18 7jj - aminoacridine hydrochloride; lidocaine hydrochloride - oral gel - aminoacridine hydrochloride (0000134509) 0.050000000000% w/w; lidocaine hydrochloride (0000073789) 0.660000000000% w/w - lidocaine
flavaco with hydrocortisone ear drops
m s jacovides & co ltd (0000003082) 8 ayios nicolaos str, lefkosia, 1511 , 21593 - polymyxin b sulfate; neomycin sulfate; aminoacridine hydrochloride; benzocaine; hydrocortisone - ear drops - polymyxin b sulfate (0001405205) 0.1%; neomycin sulfate (0001405103) 0.25%; aminoacridine hydrochloride (0000134509) 0.1%; benzocaine (0000094097) 2%; hydrocortisone (0000050237) 0.02% - hydrocortisone and antiinfectives
salicylic/target cut.sol 10% w/w
ΤΑΡΓΚΕΤ ΦΑΡΜΑ ΜΟΝΟΠΡΟΣΩΠΗ ΕΤΑΙΡΕΙΑ ΠΕΡΙΟΡΙΣΜΕΝΗΣ ΕΥΘΥΝΗΣ Δ.Τ. target pharma ΜΟΝΟΠΡΟΣΩΠΗ ΕΠΕ Μενάνδρου 54,, 104 31 104 31, Αθήνα 210.5224830 - salicylic acid - cut.sol (ΔΕΡΜΑΤΙΚΟ ΔΙΑΛΥΜΑ) - 10% w/w - salicylic acid 100mg - salicylic acid; other antipsoriatics for topical use - other antipsoriatics for topical use
salipsor cut.sol 10% (w/w)
verisfield ΜΟΝΟΠΡΟΣΩΠΗ Α.Ε. Δ.Τ. verisfield Βύρωνος 8 & Γυθείου, Χαλάνδρι 152 31 210.7475196 - salicylic acid - cut.sol (ΔΕΡΜΑΤΙΚΟ ΔΙΑΛΥΜΑ) - 10% (w/w) - salicylic acid 100mg - salicylic acid - other antipsoriatics for topical use
psorimed 10%cut.sol w/w cut.sol
dr.august wolff gmbh & co.arzneimitel, germany - salicylic acid - ΔΕΡΜΑΤΙΚΟ ΔΙΑΛΥΜΑ - 10%cut.sol w/w - ΦΑΡΜΑΚΕΥΤΙΚΟ ΠΡΟΪΟΝ
idoxuridine/a.p.r. 10% gel
help ΑΒΕΕ - idoxuridine - ΓΕΛΗ - 10%
vistogard granules 10g/pack
wellstat therapeutics corporation, usa 14200 shady grove road, suite 600 rockville, md 20850 maryland - uridine triacetate - granules (ΚΟΚΚΙΑ) - 10g/pack - uridine triacetate 10g - uridine triacetate
lonsurf
les laboratoires servier - trifluridine, tipiracil υδροχλωρική - Πρωτοπλαστικά νεοπλάσματα - Αντινεοπλασματικοί παράγοντες - colorectal cancerlonsurf is indicated in combination with bevacizumab for the treatment of adult patients with metastatic colorectal cancer (crc) who have received two prior anticancer treatment regimens including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and/or anti-egfr agents. lonsurf is indicated as monotherapy for the treatment of adult patients with metastatic colorectal cancer (crc) who have been previously treated with, or are not considered candidates for, available therapies including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and anti egfr agentsgastric cancerlonsurf is indicated as monotherapy for the treatment of adult patients with metastatic gastric cancer including adenocarcinoma of the gastroesophageal junction, who have been previously treated with at least two prior systemic treatment regimens for advanced disease.
inaqovi
otsuka pharmaceutical netherlands b.v. - cedazuridine, decitabine - Λευχαιμία, μυελοειδής - Αντινεοπλασματικοί παράγοντες - inaqovi is indicated as monotherapy for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) who are ineligible for standard induction chemotherapy.
fudr mayne pharma usa
ΙΦΕΤ ΑΕ - floxuridine - ΚΟΝΙΣ ΓΙΑ ΔΙΑΛΥΜΑ ΠΡΟΣ ΕΓΧΥΣΗ - 500 mg/vial - 0000050919 - floxuridine - 0.000000